[ <font color="blue">Neoton_3</font> <font color="blue">and_3</font> <font color="blue">thrombolytic_3</font> <font color="blue">therapy_3</font> of myocardial infarction ] . 
<br>
<br> AIM To evaluate <font color="blue">neoton_3</font> <font color="blue">therapy_3</font> effects in acute myocardial infarction ( MI ) on systolic function of the left ventricle , arrhythmia and clinical symptoms in patients on <font color="blue">thrombolytic_3</font> <font color="blue">therapy_3</font> <font color="blue">(_2</font> <font color="blue">TLT_2</font> <font color="blue">)_2</font> <font color="blue">._2</font> <font color="blue">
<br>_1</font> MATERIAL AND METHODS 106 males with Q - MI entered the study . 47 received <font color="blue">treatment_2</font> <font color="blue">without_4</font> <font color="blue">TLT_4</font> <font color="blue">and_4</font> <font color="blue">neoton_4</font> <font color="blue">,_4</font> 30 patients received <font color="blue">TLT_4</font> <font color="blue">with_4</font> <font color="blue">streptokinase_5</font> <font color="blue">preparations_5</font> <font color="blue">,_5</font> 29 patients were given <font color="blue">streptokinase_5</font> <font color="blue">preparations_5</font> <font color="blue">and_5</font> <font color="blue">neoton_5</font> <font color="blue">._5</font> Left ventricular systolic function was measured by echocardiography on day 1 , 3 , 7 , 14 , 21 and 28 ; arrhythmia was analysed at Holter monitoring in day 1 and 2 of MI . 
<br> RESULTS TLT failed to arrest progression of left ventricular dilation by the end of the hospital stay . Patients given <font color="blue">neoton_2</font> in acute period of MI had no increase in the end systolic and diastolic volumes of the left ventricle in the course of the first months after MI onset . Antiarrhythmic action of <font color="blue">neoton_2</font> manifested on MI day 2 . 
<br> CONCLUSION <font color="blue">Neoton_2</font> given to MI patients receiving <font color="blue">TLT_1</font> prevents progression of left ventricular systolic dysfunction and establishment of predictors of unfavourable outcome .